Barely Significant
← all excerpts

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.

Oncotarget · 2017 · PMC5641151 · PMID 29069808

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp<0.001actually significant
In H1299 cells, cisplatin exposure promoted the emergence of a highly significant ALDH1+ve CSC subset in PT cells (9.01±0.99%, p<0.001) and significantly enriched the ALDH1+ve subpopulation in the corresponding CisR subline from 10.5±1.02% to 19.17±2.43% (p<0.05).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.